Shares of dental products maker Dentsply Sirona Inc. (XRAY) fell sharply by over 5% in pre-market trading on Thursday, February 27th, following the company's release of weaker-than-expected fourth-quarter 2024 earnings and disappointing guidance for 2025.
For the fourth quarter, Dentsply Sirona reported adjusted earnings per share of $0.26, significantly missing Wall Street's consensus estimate of $0.43. The company's revenue of $905 million also fell short of analysts' expectations of $920.56 million.
More concerning was the company's outlook for 2025. Dentsply Sirona projected adjusted earnings per share of $1.80 to $2.00, well below the consensus forecast of $1.91. Additionally, the company guided for revenue in the range of $3.5 billion to $3.6 billion, compared to analysts' expectations of $3.734 billion. This weaker guidance was attributed to an expected 2% to 4% decline in organic sales, including a 2% hit from its Byte clear aligner business.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。